# COVID-19 Vaccine Trials - **Website:** - **Primary alias:** `covid19vaccinetrial.co.uk` ## Description The Oxford Vaccine Centre’s COVID-19 vaccine trial is a research initiative led by the Jenner Institute and Oxford Vaccine Group at the University of Oxford. Work on developing a vaccine to prevent COVID-19 began on 20 January 2020. The research team includes Professors Sarah Gilbert, Andrew Pollard, Teresa Lambe, Catherine Green and Adrian Hill, and Dr Sandy Douglas. Clinical studies are conducted with multiple sites across the UK. The initiative focuses on the development and clinical testing of the ChAdOx1 nCoV-19 vaccine. Its trial programme includes COV001 and COV002, as well as a children’s trial, and the site provides information about participation in different trial phases. It also shares research outputs, publications and information about the trials’ global impact. Participants in COV001 and COV002 can find guidance on vaccine certification for international travel, while press updates provide news about the research. The trial team emphasizes careful, timely research and directs media enquiries through its press contact form. The website also offers information about the vaccine and how it works. ## Industries - ⛑ Health - ⛑ Biotechnology and Pharmaceuticals _(under Health)_ - 🧪 Science and Education - 🧪 Biology _(under Science and Education)_ ## Logos & icons - logo _(primary)_ — PNG, SVG — [download](https://cdn.brandfetch.io/idomEpqKrN/w/820/h/258/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1793718602365) ## Colors | Name | Hex | Theme | | --- | --- | --- | | Prussian Blue | #002147 | accent | | East Bay | #445b8a | dark | | Manhattan | #f3d08f | light | ## Fonts - PT Sans Narrow — asset _(google)_ - PT Sans — asset _(google)_ --- _Source: _ _See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._